Zheng Ye, Wang Limei, Guo Jing, Wang Peng, Ji Rui, Liu Jun
Department of Gastroenterology, Shandong University Qilu Hospital, Jinan, Shandong, China.
Shandong Provincial Clinical Research Center for Digestive Disease, Shandong University Qilu Hospital, Jinan, Shandong, China.
Front Oncol. 2025 Jun 5;15:1599022. doi: 10.3389/fonc.2025.1599022. eCollection 2025.
Multiple rectal neuroendocrine tumors (RNETs) are rare rectal malignancies, and there is no consensus on their characteristics and treatments. This study aimed to explore the heterogeneity of key morphological parameters in multiple RNETs and to compare the clinicopathological characteristics between multiple and solitary RNETs.
A total of 15 patients with multiple RNETs and 89 patients with solitary RNETs treated between 2013 and 2024 were retrospectively analyzed using propensity match analysis to determine their clinicopathological characteristics. WHO grade, the expression of basal diagnostic markers (synaptophysin/chromogranin A/CD56), and somatostatin receptor 2 (SSTR2) were analyzed. Disease-free survival rates were calculated using the Kaplan-Meier method.
Multifocal RNETs were characterized by homogeneous WHO grading (93.3%) and concordant SSTR2 expression. The solitary RNETs group had a significantly higher SSTR2 positivity rate ( < 0.05) but significantly lower chromogranin A positivity rate than the multiple RNETs group ( < 0.05).
Multiple RNETs demonstrate remarkable homogeneity in core diagnostic parameters. However, compared to solitary RNETs, multifocal presentations exhibit a significantly higher propensity for metastasis/recurrence, warranting intensified therapeutic protocols and enhanced clinicopathological surveillance paradigms.
多发性直肠神经内分泌肿瘤(RNETs)是罕见的直肠恶性肿瘤,其特征和治疗方法尚无共识。本研究旨在探讨多发性RNETs关键形态学参数的异质性,并比较多发性和单发性RNETs的临床病理特征。
回顾性分析2013年至2024年期间治疗的15例多发性RNETs患者和89例单发性RNETs患者,采用倾向匹配分析确定其临床病理特征。分析世界卫生组织(WHO)分级、基础诊断标志物(突触素/嗜铬粒蛋白A/CD56)的表达以及生长抑素受体2(SSTR2)。采用Kaplan-Meier法计算无病生存率。
多灶性RNETs的特征是WHO分级一致(93.3%)和SSTR2表达一致。单发性RNETs组的SSTR2阳性率显著高于多发性RNETs组(<0.05),但嗜铬粒蛋白A阳性率显著低于多发性RNETs组(<0.05)。
多发性RNETs在核心诊断参数上表现出显著的同质性。然而,与单发性RNETs相比,多灶性表现具有显著更高的转移/复发倾向,需要强化治疗方案和加强临床病理监测模式。